Merck KGaA Pays C4 Therapeutics US$16 M Upfront for Protein Degraders |
Abstract
pdf
html
|
Lucy Haggerty |
|
Gilead Collaborates with Merus For Novel Antibody-Based Trispecific T-Cell Engagers |
Abstract
pdf
html
|
Lalit Mishra |
|
Boehringer Ingelheim Collaborates with Sosei Heptares for Antipsychotic Drugs |
Abstract
pdf
html
|
Amit Kaushik |
|
Gilead to Acquire CymaBay Therapeutics and its Liver Disease Drug for US$4.3 B |
Abstract
pdf
html
|
Lucy Haggerty |
|
AstraZeneca Buys Fusion Pharmaceuticals for US$2 B |
Abstract
pdf
html
|
Lucy Haggerty |
|
IQVIA Pharma Deals Review of 2023 |
Abstract
pdf
|
Lucy Haggerty, Ayush Saxena & Taskin Ahmed |
|